Investors want proof AI will aid drug discovery. Evidence may come in the second half
Nvidia is a fan of Recursion Pharmaceuticals. Data expected from the company will help determine valuations for stocks using AI
Read MoreNvidia is a fan of Recursion Pharmaceuticals. Data expected from the company will help determine valuations for stocks using AI
Read MoreEuropean value stocks are doing better than growth stocks right now, according to Citi analysts, who screened for those with
Read MoreNvidia is investing in Recursion, which uses AI models to identify new therapies and offers those models to its partners,
Read MoreStocks are see-sawing. As investors get jittery, BofA screened for cheaper global stocks that proved resilient during the financial crisis
Read MoreJeff Ubben’s Inclusive Capital took a stake in Bayer. The pharmaceutical giant has a big footprint in the crop science
Read MoreBank of America said these stocks have outperformed the MSCI AC World Index by 6.9% year-to-date. Source link
Read MoreStocks around the world have sold off this year, and now some are looking cheap. Here's 12 with a single
Read MoreThe legislation represents a historic expansion of Medicare's power that was fiercely opposed by the pharmaceutical industry. Source link
Read MoreThe Supreme Court has rejected Bayer's appeal to shut down thousands of lawsuits claiming that its Roundup weed killer causes
Read More